Fibromyalgia is a clinical syndrome wherein the patient experiences generalized pain and fatigue that cannot be explained by the presence of any other disorder.
It is often considered to be psychosomatic or psychogenic in nature.
It is found in approximately 2% of the population and the prevalence increases with age, most common in women 20-55 year of age

Fibromyalgia Patient Education

Patient Education

  • Critical in the optimal management of fibromyalgia
  • Goal is to help the patient understand and manage the symptoms optimally, reduce dependence on the medical system and work effectively within the system
  • Provide patient and family with information about fibromyalgia, diagnosis and all treatment options
  • It should be emphasized that fibromyalgia is a real disease and is not a deforming or a deteriorating disorder
    • Great majority of patients have normal and active lives
    • Discuss the patient's adherence or nonadherence to the agreed upon treatment strategies and other modalities
    • Confirm the diagnosis in an authoritative manner and reassure patients that they can be helped
  • Emphasize the role of stress and mood disorder, encourage fibromyalgia patients to learn simple relaxation techniques and to consider formal stress-reduction programs
  • Reinforce the importance of proper sleep hygiene
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 05 Oct 2020
Drinking more than two cups of coffee per day may just be the intervention that prevents hundreds of thousands of liver disease‐related deaths globally, a study reports.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

Stephen Padilla, Yesterday
Use of systemic corticosteroids does not reduce in-hospital mortality for patients with severe or critical coronavirus disease (COVID-19), which is in stark contrast to that observed in the RECOVERY clinical trial, according to a study in Wuhan, China.